$176 Million is the total value of Vantage Consulting Group Inc's 231 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ORGO | Exit | ORGANOGENESIS HLDGS INC | $0 | – | -21,123 | -100.0% | -0.03% | – |
| UIS | Exit | UNISYS CORP | $0 | – | -13,066 | -100.0% | -0.04% | – |
| COTY | Exit | COTY INC | $0 | – | -12,115 | -100.0% | -0.06% | – |
| AAL | Exit | AMERICAN AIRLS GROUP INC | $0 | – | -11,418 | -100.0% | -0.09% | – |
| SBNY | Exit | SIGNATURE BK NEW YORK N Y | $0 | – | -1,740 | -100.0% | -0.12% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -621 | -100.0% | -0.12% | – |
| SIVB | Exit | SVB FINANCIAL GROUP | $0 | – | -942 | -100.0% | -0.13% | – |
| FRC | Exit | FIRST REP BK SAN FRANCISCO C | $0 | – | -1,773 | -100.0% | -0.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROYALTY PHARMA PLC | 12 | Q3 2023 | 87.5% |
| ADC THERAPEUTICS SA SHS | 12 | Q3 2023 | 9.8% |
| FIBROGEN INC | 12 | Q3 2023 | 5.7% |
| COSTCO WHSL CORP NEW | 12 | Q3 2023 | 0.5% |
| WALMART INC | 12 | Q3 2023 | 0.5% |
| Sysco Corporation | 12 | Q3 2023 | 0.5% |
| Exxon Mobil Corporation | 12 | Q3 2023 | 0.5% |
| Chevron Corporation | 12 | Q3 2023 | 0.5% |
| KROGER CO | 12 | Q3 2023 | 0.5% |
| CVS Health Corporation | 12 | Q3 2023 | 0.5% |
View Vantage Consulting Group Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SYNTAX ETF TRUST | September 11, 2023 | 717,132 | 52.2% |
| SYNTAX ETF TRUST | November 08, 2022 | 156,133 | 56.8% |
| SYNTAX ETF TRUSTSold out | June 24, 2021 | 0 | 12.4% |
View Vantage Consulting Group Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-06-06 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G/A | 2023-09-11 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| SC 13G/A | 2022-11-08 |
View Vantage Consulting Group Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.